← Leaderboards
Mark J Paris
Vaccinex, Inc.
$1,064,755
Attributed
$1,064,755
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,064,755 · 3
By mechanism
R43$1,064,755 · 3
Top collaborators
No co-investigators on record.
Most similar at Vaccinex, Inc.
Same institution · by research overlap
- Melinda A Borrello$1,486,484
- Ernest S Smith$2,058,412
- Maurice Zauderer$433,400
Others in their field
Top investigators on “Vaccinia Virus”
- George R Painter · Chimerix, Inc.$36,309,505
- Daniel F. Hoft · Saint Louis University$26,271,892
- Rama Rao Amara · Emory University$21,210,426
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$18,568,832
- Bertram L. Jacobs · Arizona State University-Tempe Campus$16,467,268
- Stewart H Shuman · Sloan-Kettering Institute For Cancer Res$15,348,129
Research focus
Vaccinia VirusGenetic LibraryTechnology /Technique DevelopmentComplementary DnaTissue /Cell CulturePolymerase Chain ReactionTransfection /Expression VectorOsteoporosisGene ExpressionMesenchymeSouthern BlottingStem CellsCell Mediated Lymphocytolysis TestNeoplasm /Cancer GeneticsNeoplasm /Cancer ImmunologyOsteoblastsOsteocalcinOsteogenesisGene TargetingMolecular CloningMonoclonal AntibodyBiotechnologyBone Morphogenetic ProteinsBreast Neoplasms
Grant awards (5)
Functional Identification of Cancer Regulators$234,188
R43 · FY2005 · CA
Monoclonal Antibody Therapy to Combat Osteoporosis$217,632
R43 · FY2004 · AG
Functional Identification of Cancer Regulators$178,861
R43 · FY2004 · CA
Genetic Selection System to Clone Osteogenic Regulators$225,774
R43 · FY2003 · AG
Genetic Selection System to Clone Osteogenic Regulators$208,300
R43 · FY2002 · AG